ABSTRACT: While the role of the blood-brain barrier (BBB) is increasingly recognized in the (development of treatments targeting neurodegenerative disorders, to date, few strategies exist that enable drug delivery of non-BBB crossing molecules directly to their site of action, the brain. However, the recent advent of Nanomedicines may provide a potent tool to implement CNS targeted delivery of active compounds. Approaches for BBB crossing are deeply investigated in relation to the pathology: among the main important diseases of the CNS, this review focuses on the application of nanomedicines to neurodegenerative disorders (Alzheimer, Parkinson and Huntington's Disease) and to other brain pathologies as epilepsy, infectious diseases, multiple sclerosis, lysosomal storage disorders, strokes.
Nanoparticle transport across the blood brain barrier / Grabrucker, Andreas M.; Ruozi, Barbara; Belletti, Daniela; Pederzoli, Francesca; Forni, Flavio; Vandelli, Maria Angela; Tosi, Giovanni. - In: TISSUE BARRIERS. - ISSN 2168-8362. - STAMPA. - 4:1(2016), pp. 1-18. [10.1080/21688370.2016.1153568]
Nanoparticle transport across the blood brain barrier
RUOZI, Barbara;BELLETTI, Daniela;PEDERZOLI, FRANCESCA;FORNI, Flavio;VANDELLI, Maria Angela;TOSI, Giovanni
2016
Abstract
ABSTRACT: While the role of the blood-brain barrier (BBB) is increasingly recognized in the (development of treatments targeting neurodegenerative disorders, to date, few strategies exist that enable drug delivery of non-BBB crossing molecules directly to their site of action, the brain. However, the recent advent of Nanomedicines may provide a potent tool to implement CNS targeted delivery of active compounds. Approaches for BBB crossing are deeply investigated in relation to the pathology: among the main important diseases of the CNS, this review focuses on the application of nanomedicines to neurodegenerative disorders (Alzheimer, Parkinson and Huntington's Disease) and to other brain pathologies as epilepsy, infectious diseases, multiple sclerosis, lysosomal storage disorders, strokes.File | Dimensione | Formato | |
---|---|---|---|
proof Tissue Barriers 2016.pdf
embargo fino al 26/02/2017
Tipologia:
Post-print dell'autore (bozza post referaggio)
Dimensione
299.39 kB
Formato
Adobe PDF
|
299.39 kB | Adobe PDF | Visualizza/Apri |
grabrucker2016.pdf
non disponibili
Tipologia:
Versione dell'editore (versione pubblicata)
Dimensione
634.67 kB
Formato
Adobe PDF
|
634.67 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris